ViroPharma Company Profile

21:41 EST 11th December 2018 | BioPortfolio

At ViroPharma, we are dedicated to transforming the lives of patients through the commercialization of new and important medicines. Our goal is to focus on developing and marketing innovative products addressing unmet medical needs. We are continuing to position ourselves to do just that. We are a pharmaceutical company focused on the development and commercialization of important medicines to address serious diseases treated by physician specialists, in areas including hospital settings, transplant medicine and gastroenterology. Our marketed product, VANCOCIN® CAPSULES , is a potent oral antibiotic used by our target physician specialists, internists and gastroenterologists primarily in hospital settings, to treat two significant bacterial infections of the lower digestive tract: antibiotic-associated pseudomembranous colitis (PMC) and staphylococcal enterocolitis. Further, we are developing two promising core clinical opportunities, maribavir for prevention of cytomegalovirus infection, and our our hepatitis C compound, HCV-796. Finally, we have intranasal pleconaril, a financial value driver for ViroPharma now in the hands of Schering-Plough. We will use our current clinical product portfolio as our foundation for growth, supported by revenues from sales of Vancocin, and expand on our franchises in diseases treated by physician specialists in areas including hospital settings, transplant medicine and gastroenterology, by capitalizing on business execution and, as appropriate, prudent business development. Our goal is to become a profitable North American-based pharmaceutical company recognized worldwide for successfully developing and marketing drugs to meet the multiple needs of patients suffering from diseases that are not adequately treated by available therapies. The values on which we have built our business are important assets to us: Customer focus, quality, passion, continuous improvement, courage, teamwork and integrity. These values are evident throughout ViroPharma: the way we conduct our business, the way we communicate with our various customers, and in the manner in which we relate to one another. We are driven every day by a single human objective: to improve the lives of patients impacted by diseases with few treatment options. We have begun to do just that with Vancocin, an important medicine approved to treat two significant and debilitating lower digestive tract infections. We will continue toward that objective through our efforts to develop and commercialize additional important medicines. We will continue to invest in product and business development. We will maintain our focus on building shareholder value. We will maintain our focus on the needs of patients, physicians and payers. And, we will remain committed to quality and the continuous improvement of our performance, products and people. At ViroPharma, we are obsessed with bringing new and important medicines to market, and improving healthcare.


397 Eagleview Boulevard
United States of America


Phone: 610 458 7300
Fax: 610 458 7380

News Articles [0 Results]


Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Vancocin [ViroPharma]

VANCOCIN HCl CAPSULES (vancomycin hydrochloride capsules, USP)

Cinryze [ViroPharma Biologics]

These highlights do not include all the information needed to use CINRYZE™ safely and effectively. See full prescribing information for CINRYZE.CINRYZE™ (C1 Esterase Inhibitor [Human]) For Intrave...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing innovative products for physician specialists to enable the support of patients with s...

ViroPharma Ltd.

Natural Handmade Cosmetics & Development in Biotechnology


At ViroPharma, we are dedicated to transforming the lives of patients through the commercialization of new and important medicines. Our goal is to focus on developing and marketing innovative products...

More Information about "ViroPharma" on BioPortfolio

We have published hundreds of ViroPharma news stories on BioPortfolio along with dozens of ViroPharma Clinical Trials and PubMed Articles about ViroPharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ViroPharma Companies in our database. You can also find out about relevant ViroPharma Drugs and Medications on this site too.

Quick Search


Relevant Topics

Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Corporate Database Quicklinks

Searches Linking to this Company Record